Placebo (10 mM sodium acetate, 9.0% (w/v) sucrose, 0.02% (w/v) polysorbate 20, pH 5.2), EPINEPHRINE , Briquilimab
JSP-CP-011
Phase 2 small_molecule active
Quick answer
Placebo (10 mM sodium acetate, 9.0% (w/v) sucrose, 0.02% (w/v) polysorbate 20, pH 5.2), EPINEPHRINE , Briquilimab for Chronic Spontaneous Urticaria is a Phase 2 program (small_molecule) at Jasper Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jasper Therapeutics
- Indication
- Chronic Spontaneous Urticaria
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active